About 520 results

ALLMedicine™ Allergic Bronchopulmonary Aspergillosis Center

Research & Reviews  190 results

Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronch...
Allergy Lukaszewicz R, Mahay G et. al.

Jul 13th, 2021 - Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronchopulmonary Aspergillosis.|2021|Lukaszewicz R,Mahay G,Boyer O,Martinet J,|

Variation of virulence of five Aspergillus fumigatus isolates in four different infecti...
PloS One; Keizer EM, Valdes ID et. al.

Jul 10th, 2021 - Conidia of Aspergillus fumigatus are inhaled by humans on daily basis. As a consequence, these conidia can cause infections that differ in severity ranging from allergic bronchopulmonary aspergillosis to invasive aspergillosis. In this study we co...

Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal ast...
PloS One; Kwizera R, Bongomin F et. al.

May 29th, 2021 - Diagnosis of fungal allergies in asthma remains problematic in low-and middle-income countries due to non-availability of point-of-care testing. In this study, we aimed to evaluate the performance of an Aspergillus immunochromatographic technology...

Clinical characteristics of allergic bronchopulmonary aspergillosis in patients with an...
The Journal of Asthma : Official Journal of the Associati... Wang S, Zhang J et. al.

Mar 19th, 2021 - Allergic bronchopulmonary aspergillosis (ABPA) is classified radiologically as serologic ABPA (ABPA-S) or ABPA with central bronchiectasis (ABPA-CB). This retrospective case series study aimed to describe and compare the clinical characteristics o...

Role of circulating microRNA-132 in allergic bronchopulmonary aspergillosis: A case-con...
Immunobiology Esawy MM, Baioumy SA et. al.

Mar 19th, 2021 - Allergic bronchopulmonary aspergillosis (ABPA) is an allergic respiratory disease. In the current study, we aimed to evaluate the roles of miRNA-21 and miRNA132 as biomarkers in the diagnosis of ABPA. A total of 30 controls, 30 allergic asthmatic ...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  8 results

A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis

Aug 23rd, 2018 - The management of allergic bronchopulmonary aspergillosis (ABPA) includes two important aspects namely institution of immunosuppressive therapy in the form of glucocorticoids to control the immunologic activity, and close monitoring for detection ...

A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma

Aug 23rd, 2018 - Allergic bronchopulmonary aspergillosis (ABPA) is a immunological pulmonary disorder caused by hypersensitive reaction to spores of Aspergillus fumigatus. The prevalence of disease is about 1-2% in asthmatics and 2-15% in patients with cystic fibr...

Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis

Mar 29th, 2018 - Many patients with cystic fibrosis (CF) cough up mucus or have throat cultures that grow a common fungus called Aspergillus. In patients with CF, aspergillus is not known to cause direct damage to the lungs, but some patients respond with an aller...

Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).

Jan 26th, 2018 - Compare the incidence of severe clinical exacerbations in the treatment of ABPA, between a strategy with a maintenance treatment and a conventional strategy without antifungal maintenance therapy.

Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis

Aug 30th, 2017 - Allergic bronchopulmonary Aspergillosis (ABPA) is a pulmonary hypersensitivity disease mediated by an allergic response to Aspergillus fumigates. ABPA occurs in, 10% of cystic fibrosis (CF) patients and may lead to acute worsening of respiratory s...

see more →

News  1 results

Fast Five Quiz: How Much Do You Know About Asthma?

Jun 4th, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

see more →

Patient Education  1 results see all →